James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

This Headwind Makes Avis Budget Group Inc. Stock Tricky to Handicap

If you own CAR stock, or are about to invest in Avis Budget, keep tabs on this rarely-watched auto market trend.

Altria Group Inc (MO) Stock Hangs On for Another Quarter

MO stock is still quite tough to see as a stock with a long-term future, but don't deny Altria Group is giving it the ol' college try.

After Earnings, Investors Are Worried About eBay Inc’s Near-Term Profits

eBay stock tumbled to the tune of 6% after Wednesday's close after the online auction company struggled to find a payoff on investments.

If You’re Tired of the Speculation Game, Take a Look at Blackstone Group LP Stock

Blackstone Group prepackages equity in companies that you can't normally buy, making BX stock a very compelling alternative to "normal" stocks.

Some Pro Perspective on This Bond Market Volatility

The falling bond market and rising interest rates are a poor reason for investors to panic in and of themselves.

Buy the Post-Earnings Lull from Johnson & Johnson

JNJ may be in the red in response to a so-so first-quarter report, but look at Johnson & Johnson stock through all the noise and there's still a lot to like. With a forward-looking price to earnings ratio of 15.1, investors with a long view may want to get into JNJ stock.

UnitedHealth Group Inc Looks Like It May Be Unstoppable

UnitedHealth stock posted stellar first-quarter results. UNH may not be a buy immediately after its post-earnings pop but it's tough to see anything slowing the health insurer down. Investors should add UNH stock to their watchlists if they don't own it already.

Buy Freeport-McMoRan Inc on the Post-Earnings Dip

FCX stock is down 12% on Tuesday thanks to a modest earnings shortfall, but Freeport-McMoRan is actually on an impressive growth tear.

10 Stocks You Need to Banish Right Now

Add these names to a list of stocks to sell before things go from bad to worse. Their charts and underlying stories look troubled in a big way.

Hard Data on eSports Sponsorships Only Can Help Activision Blizzard, Inc. Stock

It won't make or break Activision stock right away, but this is the next era of the video gaming market, and well worth watching.